6.03
price up icon0.42%   0.025
 
loading
Biovie Inc stock is traded at $6.03, with a volume of 33,164. It is up +0.42% in the last 24 hours and up +547.69% over the past month. BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$6.005
Open:
$6
24h Volume:
33,164
Relative Volume:
0.09
Market Cap:
$11.15M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-1.1596
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
-19.39%
1M Performance:
+547.69%
6M Performance:
+265.45%
1Y Performance:
+58.56%
1-Day Range:
Value
$5.7356
$6.20
1-Week Range:
Value
$5.7356
$7.7493
52-Week Range:
Value
$0.62
$9.56

Biovie Inc Stock (BIVI) Company Profile

Name
Name
Biovie Inc
Name
Phone
775-888-3162
Name
Address
680 W NYE LANE, CARSON CITY
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
BIVI's Discussions on Twitter

Compare BIVI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
BIVI
Biovie Inc
6.03 11.15M 0 -25.56M -19.35M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-22 Initiated Cantor Fitzgerald Overweight
Jan-15-21 Initiated B. Riley Securities Buy

Biovie Inc Stock (BIVI) Latest News

pulisher
Aug 01, 2025

What are the latest earnings results for BioVie Inc.Chart Pattern Forecasts For Consistent Profits - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

What makes BioVie Inc. stock price move sharplyFree Stock Target Finder That Work - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

How strong is BioVie Inc. company’s balance sheetDaily Trading Signals That Work - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Why BioVie Inc. stock attracts strong analyst attentionValue Driven Trading Forecast Analysis - beatles.ru

Aug 01, 2025
pulisher
Jul 31, 2025

When is BioVie Inc. stock expected to show significant growthChart Pattern Insights Backed By Experts - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What institutional investors are buying BioVie Inc. stockChart Pattern Ideas For Fast Growth - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What are BioVie Inc. company’s key revenue driversEarnings Report Alerts To Watch Now - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 29, 2025

Intraday Charts Show Spike in BioVie Inc. ActivityTrade Timing Strategy With Technical Data Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Trading Bots Trigger Alerts on BioVie Inc. ActivityWeekly Top Gainers Forecast Watchlist Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Traders Consider Averaging Down in BioVie Inc.Conservative Entry for High Return Setup Backed - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Is BioVie Inc. stock overvalued or undervaluedWealth Building Target Finder To Watch Now - jammulinksnews.com

Jul 29, 2025
pulisher
Jul 28, 2025

What catalysts could drive BioVie Inc. stock higher in 2025Smart Portfolio Data Feed For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 22:20:34 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How high can BioVie Inc. stock price go in 2025Entry and Exit Strategy Optimizer Tool Tested - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell BioVie Inc. stock in 2025Build wealth steadily with expert advice - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does BioVie Inc. stock perform well during market downturnsRapid wealth multiplication - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is BioVie Inc. company’s growth strategyAchieve breakthrough financial results today - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about BioVie Inc.Capitalize on fast-moving trading opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate BioVie Inc. as a “Buy”Unstoppable trading performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

How does BioVie Inc. compare to its industry peersFind market-beating stocks for your portfolio - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in BioVie Inc. stockFree Capital Allocation Plans - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of BioVie Inc. stockTrack stocks with high upside potential easily - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy BioVie Inc. stockFree Stock Selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 07:54:24 - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Published on: 2025-07-26 14:40:51 - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Is BioVie Inc. a good long term investmentAccelerated earnings growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about BioVie Inc. stockConsistently high returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Is BioVie Inc. stock overhyped or has real potentialTremendous wealth creation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Biovie stock rises after drug shows age deceleration in Alzheimer’s patients - Investing.com India

Jul 25, 2025
pulisher
Jul 24, 2025

BioVie Presented Data Highlighting that Patients Treated - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What drives BioVie Inc. stock priceUnprecedented market success - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

BioVie presents data on Bezisterim at WCAG-2025 - TipRanks

Jul 24, 2025

Biovie Inc Stock (BIVI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):